Urot, Ronilo S.
HRN: 21-47-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/24/2022
06/30/2022
IVTT
4.5g
Q8
Still With Signs Of Previous Infection
Waiting Final Action
Indication: Empirical Escalation Type of Infection: BloodstreamBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes